Literature DB >> 19424163

Diet-induced renal changes in Zucker rats are ameliorated by the superoxide dismutase mimetic TEMPOL.

Philip J Ebenezer1, Nithya Mariappan, Carrie M Elks, Masudul Haque, Joseph Francis.   

Abstract

Diabetic nephropathy is the leading cause of renal failure in the United States. The obese Zucker rat (OZR; fa/fa) is a commonly used model of type 2 diabetes and metabolic syndrome (MetS), and of the nephropathy and renal oxidative stress commonly seen in these disorders. Heterozygous lean Zucker rats (LZRs; fa/+) are susceptible to high-fat diet (HFD)-induced obesity and MetS. The present study was designed to investigate whether 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPOL), a membrane-permeable radical scavenger, could alleviate the renal effects of MetS in OZR and LZR fed a HFD, which resembles the typical "Western" diet. OZR and LZR were fed a HFD (OZR-HFD and LZR-HFD) or regular diet (OZR-RD and LZR-RD) and allowed free access to drinking water or water containing 1 mmol/l TEMPOL for 10 weeks. When compared to OZR-RD animals, OZR-HFD animals exhibited significantly higher levels of total renal cortical reactive oxygen species (ROS) production, plasma lipids, insulin, C-reactive protein, blood urea nitrogen (BUN), creatinine (Cr), and urinary albumin excretion (P < 0.05); these changes were accompanied by a significant decrease in plasma high-density lipoprotein levels (P < 0.05). The mRNA expression levels of desmin, tumor necrosis factor-alpha (TNF-alpha), nuclear factor kappaB (NFkappaB), and NAD(P)H oxidase-1 (NOX-1) were significantly higher in the renal cortical tissues of OZR-HFD animals; NFkappaB p65 DNA binding activity as determined by electrophoretic mobility shift assay was also significantly higher in these animals. The same trends were noted in LZR-HFD animals. Our data demonstrate that TEMPOL may prove beneficial in treating the early stages of the nephropathy often associated with MetS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19424163      PMCID: PMC2784093          DOI: 10.1038/oby.2009.137

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  39 in total

1.  AHA Science Advisory: Lyon Diet Heart Study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I Dietary Pattern on Cardiovascular Disease.

Authors:  P Kris-Etherton; R H Eckel; B V Howard; S St Jeor; T L Bazzarre
Journal:  Circulation       Date:  2001-04-03       Impact factor: 29.690

2.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage.

Authors:  T Nishikawa; D Edelstein; X L Du; S Yamagishi; T Matsumura; Y Kaneda; M A Yorek; D Beebe; P J Oates; H P Hammes; I Giardino; M Brownlee
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

3.  Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats.

Authors:  J P Corsetti; J D Sparks; R G Peterson; R L Smith; C E Sparks
Journal:  Atherosclerosis       Date:  2000-02       Impact factor: 5.162

4.  Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes.

Authors:  T M Coimbra; U Janssen; H J Gröne; T Ostendorf; U Kunter; H Schmidt; G Brabant; J Floege
Journal:  Kidney Int       Date:  2000-01       Impact factor: 10.612

5.  Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress.

Authors:  J H Bae; E Bassenge; K B Kim; Y N Kim; K S Kim; H J Lee; K C Moon; M S Lee; K Y Park; M Schwemmer
Journal:  Atherosclerosis       Date:  2001-04       Impact factor: 5.162

6.  Podocyte injury underlies the progression of focal segmental glomerulosclerosis in the fa/fa Zucker rat.

Authors:  N Gassler; M Elger; B Kränzlin; W Kriz; N Gretz; B Hähnel; H Hosser; I Hartmann
Journal:  Kidney Int       Date:  2001-07       Impact factor: 10.612

7.  High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells.

Authors:  T Inoguchi; P Li; F Umeda; H Y Yu; M Kakimoto; M Imamura; T Aoki; T Etoh; T Hashimoto; M Naruse; H Sano; H Utsumi; H Nawata
Journal:  Diabetes       Date:  2000-11       Impact factor: 9.461

8.  Chronic NF-{kappa}B blockade reduces cytosolic and mitochondrial oxidative stress and attenuates renal injury and hypertension in SHR.

Authors:  Carrie M Elks; Nithya Mariappan; Masudul Haque; Anuradha Guggilam; Dewan S A Majid; Joseph Francis
Journal:  Am J Physiol Renal Physiol       Date:  2008-12-10

9.  The high-fat-fed lean Zucker rat: a spontaneous isocaloric model of fat-induced insulin resistance associated with muscle GSK-3 overactivity.

Authors:  Erik J Henriksen; Mary K Teachey; Katherine A Lindborg; Cody J Diehl; Alan N Beneze
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-04-02       Impact factor: 3.619

10.  Atheroprotective effect of human apolipoprotein A5 in a mouse model of mixed dyslipidemia.

Authors:  Roxane M Mansouri; Eric Baugé; Philippe Gervois; Jamila Fruchart-Najib; Catherine Fiévet; Bart Staels; Jean-Charles Fruchart
Journal:  Circ Res       Date:  2008-07-24       Impact factor: 17.367

View more
  30 in total

1.  Eight weeks of dietary overfeeding increases renal filtration rates in humans: implications for the pathogenesis of diabetic hyperfiltration.

Authors:  J D Covington; G A Bray; L M Redman; D L Johannsen; E Ravussin
Journal:  J Intern Med       Date:  2015-06-15       Impact factor: 8.989

2.  Obesity-induced changes in kidney mitochondria and endoplasmic reticulum in the presence or absence of leptin.

Authors:  Shankar Munusamy; Jussara M do Carmo; Jonathan P Hosler; John E Hall
Journal:  Am J Physiol Renal Physiol       Date:  2015-08-19

3.  The nitroxide radical TEMPOL prevents obesity, hyperlipidaemia, elevation of inflammatory cytokines, and modulates atherosclerotic plaque composition in apoE-/- mice.

Authors:  Christine H J Kim; James B Mitchell; Christina A Bursill; Anastasia L Sowers; Angela Thetford; John A Cook; David M van Reyk; Michael J Davies
Journal:  Atherosclerosis       Date:  2015-03-16       Impact factor: 5.162

Review 4.  Central adiposity, systemic inflammation, and the metabolic syndrome.

Authors:  Carrie M Elks; Joseph Francis
Journal:  Curr Hypertens Rep       Date:  2010-04       Impact factor: 5.369

Review 5.  Cardiac NO signalling in the metabolic syndrome.

Authors:  O Pechánová; Z V Varga; M Cebová; Z Giricz; P Pacher; P Ferdinandy
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

6.  Deletion of UCP1 enhances ex vivo aortic vasomotor function in female but not male mice despite similar susceptibility to metabolic dysfunction.

Authors:  Nathan C Winn; Zachary I Grunewald; Michelle L Gastecki; Makenzie L Woodford; Rebecca J Welly; Stephanie L Clookey; James R Ball; T'Keaya L Gaines; Natalia G Karasseva; Jill A Kanaley; Harold S Sacks; Victoria J Vieira-Potter; Jaume Padilla
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-06-27       Impact factor: 4.310

7.  Prediabetic nephropathy as an early consequence of the high-calorie/high-fat diet: relation to oxidative stress.

Authors:  Hanna Shevalye; Sergey Lupachyk; Pierre Watcho; Roman Stavniichuk; Khaled Khazim; Hanna E Abboud; Irina G Obrosova
Journal:  Endocrinology       Date:  2012-01-10       Impact factor: 4.736

8.  Effects of pyrrolidine dithiocarbamate on high-fat diet-induced metabolic and renal alterations in rats.

Authors:  Philip J Ebenezer; Nithya Mariappan; Carrie M Elks; Masudul Haque; Zohreh Soltani; Efrain Reisin; Joseph Francis
Journal:  Life Sci       Date:  2009-07-23       Impact factor: 5.037

9.  High-fat diet-induced obesity Rat model: a comparison between Wistar and Sprague-Dawley Rat.

Authors:  Cláudia Marques; Manuela Meireles; Sónia Norberto; Joana Leite; Joana Freitas; Diogo Pestana; Ana Faria; Conceição Calhau
Journal:  Adipocyte       Date:  2015-07-15       Impact factor: 4.534

10.  Oxidative Stress: A Potential Therapeutic Target in Placental Malaria.

Authors:  Demba Sarr; Caitlin A Cooper; Tara C Bracken; Omar Martinez-Uribe; Tamas Nagy; Julie M Moore
Journal:  Immunohorizons       Date:  2017-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.